Showing results (1301-1310 of 1,518) with videos related to

Sort By:
Pageof 152
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trialF Barlesi, A Scherpereel, V Gorbunova, et al.
American Journal of Primatology|February 23, 2023
Influence of landscape structure on previous exposure to Leptospira spp. and Brucella abortus in free-living neotropical primates from southern BrazilElisandro O Dos Santos, Vinícius F Klain, Sebastián B Manrique, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancerE-H Tan, R Ramlau, A Pluzanska, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1Solange Peters, Meredith M Regan, Luis G Paz-Ares, et al.
The Journal of Biological Chemistry|June 14, 2024
A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2Verena Dederer, Marta Sanz Murillo, Eva P Karasmanis, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 14, 2022
Shoe Allergens: A Retrospective Analysis of Cross-sectional Data From the North American Contact Dermatitis Group, 2005-2018Amber Reck Atwater, Raina Bembry, Cynthia L Green, et al.
JTO Clinical and Research Reports|September 30, 2021
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042Aaron S Mansfield, Roy S Herbst, Gilberto de Castro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trialA S Mansfield, A Każarnowicz, N Karaseva, et al.
Clinical Lung Cancer|January 27, 2018
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL TrialSuresh S Ramalingam, Maurice Pérol, Martin Reck, et al.
Journal of the American Academy of Dermatology|August 8, 2022
Hand and foot dermatitis in patients referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2001-2018Jonathan I Silverberg, Nisha Patel, Erin M Warshaw, et al.
Pageof 152